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Abstract  1 
Women with hypertensive disorders in pregnancy are at increased lifetime risk for 2 
cardiovascular disease. We examined the offspring’s cardiovascular risk profile in young 3 
adulthood, and also their siblings’ cardiovascular risk profile.  4 
From the HUNT Study in Norway 15 778 participants (mean age 29 years), including 210 5 
sibling groups, were linked to information from the Medical Birth Registry of Norway. Blood 6 
pressure, anthropometry, serum lipids and CRP were assessed.   7 
706 participants were born after exposure to maternal hypertension in pregnancy: 336 mothers 8 
had gestational hypertension, 343 had term preeclampsia, and 27 had preterm preeclampsia. 9 
Offspring whose mothers had hypertension in pregnancy had 2.7 (95% CI 1.8-3.5) mmHg 10 
higher systolic blood pressure, 1.5 (0.9-2.1) mmHg higher diastolic blood pressure, 0.66 11 
(0.31-1.01) kg/m2 higher BMI, and 1.49 (0.65-2.33) cm wider waist circumference, compared 12 
with offspring of normotensive pregnancies. Similar differences were observed for gestational 13 
hypertension and term preeclampsia, but term preeclampsia was also associated with higher 14 
concentrations of non-HDL cholesterol (0.14 mmol/L, 0.03-0.25) and triglycerides (0.13 15 
mmol/L, 0.06-0.21). Siblings born after a normotensive pregnancy had nearly identical risk 16 
factor levels as siblings who were born after maternal hypertension.  17 
Offspring born after maternal hypertension in pregnancy have a more adverse cardiovascular 18 
risk profile in young adulthood than offspring of normotensive pregnancies. Their siblings, 19 
born after a normotensive pregnancy, have a similar risk profile, suggesting that shared genes 20 
or lifestyle may account for the association, rather than an intrauterine effect. All children of 21 
mothers who have experienced hypertension in pregnancy may be at increased lifetime risk of 22 
cardiovascular disease. 23 
 24 
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 4 
Introduction 1 
Hypertensive disorders of pregnancy include gestational hypertension and preeclampsia.1 In 2 
addition to hypertension, preeclampsia is characterized by proteinuria and is a leading cause 3 
of maternal and perinatal morbidity.2-4 It is well established that women with a history of 4 
hypertension in pregnancy are at increased risk of cardiovascular disease (CVD) later in life,5-5 
8 and their offspring may also have an increased lifetime risk of CVD.9-11 Children and 6 
adolescents whose mothers had preeclampsia appear to have higher body mass index (BMI) 7 
and blood pressure than others, but it is not entirely clear if other cardiovascular risk factors, 8 
such as serum lipids, may also differ.12 Also, it remains to be determined whether siblings 9 
born after a hypertensive pregnancy, differ in their cardiovascular profile, compared to 10 
siblings born after a normotensive pregnancy. Such an analysis might help clarify whether the 11 
children’s risk factors could be attributed to the hypertensive pregnancy, or whether shared 12 
genes or shared lifestyle are equally relevant.  13 
 Using a prospective cohort design, we investigated whether intrauterine exposure to 14 
maternal hypertensive disorders (gestational hypertension, term preeclampsia or preterm 15 
preeclampsia) is associated with cardiovascular risk factors in young adulthood. We also 16 
compared cardiovascular risk factors between siblings discordant for in utero exposure to 17 
maternal hypertension. 18 
 19 
Materials and methods 20 
Study population 21 
The Nord-Trøndelag Health Study (the HUNT Study) consists of three population-based 22 
surveys in Nord-Trøndelag county in Norway: HUNT1 (1984-86), HUNT2 (1995-97) and 23 
HUNT3 (2006-08). At each survey, all residents 20 years of age or older were invited to 24 
participate. The number of participants was 77 212 (89.4 % of those invited) in HUNT1, 61 25 
 5 
215 (69.5 %) in HUNT2, and 50 807 (54.1 %) in HUNT3.13 The HUNT Study comprises 1 
extensive questionnaires, clinical examinations and blood samplings (second and third 2 
surveys), and provides information on socioeconomic status, health related behavior, and a 3 
broad range of self-reported symptoms and prevalent diseases. More than 97 % of the 4 
population is of European ancestry.14 The study has been described in detail elsewhere.13, 14 5 
 We used the unique personal identity number of Norwegian citizens to link individual-6 
level HUNT data to information recorded in the Medical Birth Registry of Norway (MBRN). 7 
The MBRN has registered information for all births in Norway since 1967, as reported on a 8 
standardized form filled in at the birth clinics. The form includes information on demographic 9 
variables, maternal health before and during pregnancy, complications and registrations 10 
during pregnancy and delivery, and health status of the newborn. The form is typically 11 
completed by the responsible midwife and returned within a week of the delivery. In the 12 
present study, we included all 15 873 singletons born in 1967 or later who subsequently 13 
participated in HUNT2 or HUNT3 as adults and excluded 95 participants without information 14 
on cardiovascular risk factors, leaving 15 778 participants (with a total of 19 596 HUNT 15 
examinations) for analysis. For 13 127 of them (83%, with 16 584 HUNT examinations), 16 
additional maternal information on socioeconomic status and cardiovascular risk factors was 17 
available because their mothers had also participated in one or more of the HUNT surveys. 18 
For the majority of participants, maternal information from the HUNT surveys was collected 19 
after the index pregnancy. The study was approved by the regional committee for medical and 20 
health research ethics (REC Central). 21 
 22 
Classification of hypertensive disorders in pregnancy 23 
The clinical criteria for hypertensive disorders in pregnancy in the MBRN are in accordance 24 
with the recommendations of the American College of Obstetricians and Gynecologists.15 25 
 6 
Gestational hypertension is defined as sustained increase in blood pressure, ≥140 mmHg 1 
systolic and/or 90 mmHg diastolic pressure, with onset after 20 weeks of gestation. The 2 
diagnostic criteria for preeclampsia are similar, but in addition, proteinuria (at least 0.3 g/24 3 
hours or ≥1+ on a semiquantitative dipstick) after gestational week 20 is also required. In this 4 
study, we defined a hypertensive disorder in pregnancy as the presence of either gestational 5 
hypertension, term preeclampsia (preeclampsia with delivery ≥37 weeks of pregnancy), or 6 
preterm preeclampsia (preeclampsia with delivery <37 weeks of pregnancy).  7 
 8 
Cardiovascular risk factors in the HUNT surveys 9 
Specially trained nurses and technicians conducted the clinical examinations in the HUNT 10 
surveys. Blood pressure was measured with the person seated using a sphygmomanometer 11 
(HUNT1) or a Dinamap 845 XT (Critikon, Tampa, FL) oscillometer (HUNT2 and 3), and the 12 
pressure was measured two (HUNT1) or three (HUNT2 and 3) times with one minute 13 
intervals. For HUNT1, we used the mean of the two measurements. For HUNT2 and HUNT3, 14 
we used the mean of the second and third measurement, and if a third measurement was not 15 
conducted (12 % of measurements in HUNT3), only the second measurement was used. At 16 
HUNT2 and HUNT3, cuff size was adjusted to the participant’s arm circumference. Weight 17 
was recorded to the nearest 0.5 kg wearing light clothes but without shoes, and height was 18 
measured to the nearest cm. Body mass index (BMI) was calculated as weight (in kg) divided 19 
by the squared value of height (in meters). Waist and hip circumference were measured to the 20 
nearest cm, using the level of the umbilicus and at the widest part of the hip. Waist-hip ratio 21 
was calculated as the ratio of the two measurements.  22 
Blood samples were collected in a non-fasting state and analyzed at the Central 23 
Laboratory, Levanger Hospital, Nord-Trøndelag Hospital Trust, using a Hitachi 911 24 
Autoanalyzer (Mito, Japan) with reagents from Boehringer Mannheim (Mannheim, Germany; 25 
 7 
for serum lipids) or Roche (Basel, Switzerland; for C-reactive protein (CRP)) in HUNT2 and 1 
an Architect ci8200 with reagents from Abbott (Abbott Ireland, Longford, Ireland; and 2 
Abbott Laboratories, Abbott Park, IL) in HUNT3. Serum concentrations of total cholesterol 3 
were analyzed by enzymatic cholesterol esterase methodology, HDL cholesterol by enzymatic 4 
cholesterol esterase (HUNT2) or accelerator selective detergent methods (HUNT3), 5 
triglycerides by enzymatic colorimetric (HUNT2) or glycerol phosphate oxidase methods 6 
(HUNT3), and CRP by latex immunoassay methodology. Non-HDL cholesterol was 7 
calculated as the difference between total and HDL cholesterol concentrations.  8 
 9 
Statistical analyses  10 
Using linear regression analysis, we compared CVD risk factors of adult offspring born after 11 
hypertensive pregnancy to those among offspring born after normotensive pregnancy. Thus, 12 
we compared means of systolic and diastolic blood pressure, BMI, waist circumference, 13 
waist-hip ratio, and serum concentrations of HDL cholesterol, non-HDL cholesterol, 14 
triglycerides and CRP. We also examined these factors by subtype of maternal hypertensive 15 
disorder: gestational hypertension, term preeclampsia, or preterm preeclampsia. CRP and 16 
triglycerides were analyzed log-transformed due to a non-normal distribution. We used a 17 
clustered sandwich estimator to account for repeated measurements within each offspring. In 18 
the main analyses, we adjusted for age (continuous variable), sex, maternal parity and HUNT 19 
survey. In a separate analysis among offspring whose mothers had also participated in the 20 
HUNT Study, we examined whether the observed differences in cardiovascular risk factors in 21 
young adulthood persisted after adjustment for maternal cardiovascular risk factors recorded 22 
in the HUNT Study. For that purpose, we first adjusted for maternal smoking (current smoker 23 
versus non-smoker) and education (≤9, 10-12, or >12 years), and then added maternal BMI 24 
(continuous) and systolic and diastolic blood pressure (continuous) to the model. We used 25 
 8 
maternal information collected at the earliest HUNT examination in which the mother had 1 
participated.  2 
 Using a fixed-effects linear model, we also compared cardiovascular risk factors 3 
within siblings born by the same mother, where at least one was exposed to hypertension in 4 
pregnancy and one was not. We adjusted for age, sex, maternal parity and HUNT survey. 5 
Finally, we compared cardiovascular risk factors among offspring born after hypertensive 6 
pregnancy, and among offspring born after normotensive pregnancy but whose mother had at 7 
least one hypertensive pregnancy, to offspring of women with no record of hypertensive 8 
pregnancy. We used a mixed-effects linear regression model to account for multiple offspring 9 
by the same mother, and we adjusted for age, sex, maternal parity and HUNT survey. In these 10 
analyses, we included information from the latest HUNT examination in which the offspring 11 
had participated. Stata statistical software version 13.1 (College Station, TX) was used for the 12 
statistical analyses. 13 
 14 
Results 15 
Characteristics of the participants are described in Table 1. Among 15 778 participants, there 16 
were 19 596 examinations: 336 (2%) participants were exposed to gestational hypertension in 17 
utero, 343 (2%) were exposed to term preeclampsia, 27 (0.2%) to preterm preeclampsia, and 18 
15 072 (96%) were born after a normotensive pregnancy. Mean age at attendance was 28.9 19 
(SD 6.2) years.  20 
Participants whose mothers had any hypertensive disorder in pregnancy had 2.7 (95% 21 
CI 1.8-3.5) mmHg higher systolic blood pressure, 1.5 (0.9-2.1) mmHg higher diastolic blood 22 
pressure, 0.66 (0.31-1.01) kg/m2 higher BMI, and 1.49 (0.65-2.33) cm wider waist 23 
 9 
circumference, compared with participants born after a normotensive pregnancy, adjusted for 1 
age, sex, parity and HUNT survey (Table 2).  2 
Among subtypes of hypertensive pregnancies, gestational hypertension and term 3 
preeclampsia were associated with similar increases in blood pressure, BMI and waist 4 
circumference in the offspring. Offspring of mothers who had term preeclampsia also had 5 
slightly higher serum concentrations of non-HDL cholesterol (0.14 mmol/L, 0.03-0.25) and 6 
triglycerides (0.13 mmol/L, 0.06-0.21). In contrast, there was no strong evidence of 7 
differences between offspring born after preterm preeclampsia, compared with the 8 
normotensive group (Table 2). Offspring in the preterm preeclampsia group had 35% higher 9 
CRP than offspring in the normotensive group, but due to small numbers, the precision of the 10 
difference was low.  11 
In a sub-group analysis (N=13 127 participants with 16 584 HUNT examinations) we 12 
adjusted for maternal blood pressure and BMI to find out whether, or to which degree, the 13 
observed differences between offspring could be attributed to maternal characteristics. 14 
Differences in BMI and waist circumference between offspring of hypertensive and 15 
normotensive pregnancies were attenuated by 80-90% after this adjustment, and most of the 16 
attenuation was due to adjustment for maternal BMI. Similarly, associations with blood 17 
pressure were attenuated by 60-70%, and most of the attenuation was due to adjustment for 18 
maternal blood pressure (Table 3). 19 
To further explore the increased cardiovascular risk factor levels in offspring born 20 
after hypertensive conditions in pregnancy, we compared cardiovascular risk factors among 21 
siblings discordant for the exposure (N=472 participants within 210 sibships; characteristics 22 
given in Table 4). We found no evidence of clear differences in cardiovascular risk factors 23 
between siblings born by the same mother, where at least one sibling was born after a 24 
hypertensive pregnancy (Table 5). Similarly, there were no clear differences in cardiovascular 25 
 10 
risk factors among offspring born after a hypertensive pregnancy (N=706) and offspring born 1 
after a normotensive pregnancy but whose mother had at least one hypertensive pregnancy 2 
(N=653) (Table 6). 3 
In the main analysis, participants born to mothers with pre-pregnancy hypertension 4 
without superimposed preeclampsia (N=27) were included in the normotensive group. In a 5 
sensitivity analysis, we excluded these participants, and the results remained essentially 6 
unchanged (results not shown).  7 
  8 
Discussion 9 
In this prospective study of approximately 16 000 young adults, offspring whose mothers had 10 
hypertension in pregnancy had an adverse cardiovascular risk factor profile in young 11 
adulthood (mean: 29 years of age), compared to offspring of normotensive pregnancies. 12 
Intrauterine exposure to maternal gestational hypertension or term preeclampsia was 13 
associated with higher systolic and diastolic blood pressure, BMI and waist circumference, 14 
and in the term preeclampsia group, non-HDL cholesterol and triglyceride concentrations 15 
were slightly higher. Among siblings, we found a cardiovascular risk factor profile that was 16 
nearly identical between those who were exposed to maternal hypertension in pregnancy, and 17 
siblings who were born after a normotensive pregnancy.  18 
In this study we were able to follow a large number of offspring from birth until young 19 
adulthood. Maternal hypertensive disorders in pregnancy were reported to the MBRN after 20 
birth, and therefore, this information could not be influenced by future health of the offspring. 21 
Moreover, the positive predictive value of preeclampsia and gestational hypertension 22 
diagnoses registered in the MBRN is good, although some cases of preeclampsia may be 23 
misclassified as gestational hypertension.16, 17 The collection of cardiovascular risk factors was 24 
 11 
standardized and conducted by trained nurses or health care technicians who were unaware of 1 
the pregnancy complications. The attendance at the two surveys was 69.5% and 54.1%; 2 
however, attendance was as low as 49% and 32% for the age groups with available perinatal 3 
information.13 Because a selective participation cannot be ruled out, the attendance is a 4 
limitation of this study. However, the prevalence of preeclampsia in our study population was 5 
similar to nation-wide prevalence data for the same birth cohorts18, suggesting that 6 
participation did not vary by exposure to preeclampsia. Also, selective participation may have 7 
influenced our findings only if the associations of hypertensive pregnancy disorders with 8 
future cardiovascular risk factors differed between those who participated at the HUNT Study 9 
and those who did not.  The blood sampling was non-fasting, which could have caused a non-10 
differential misclassification between comparison groups, and typically result in a bias 11 
towards the null value. In our study, such a bias could have influenced the results for 12 
triglycerides, due to daily fluctuations depending on diet, but less likely for HDL and non-13 
HDL cholesterol, which are more stable.19 Moreover, the maternal information used in the 14 
analysis in Table 3 was partly measured before pregnancy, and partly after the pregnancy, and 15 
these measurements were assumed to be equally relevant when maternal cardiovascular risk 16 
factors were taken into account. This may be a questionable approach, but the results of 17 
another study of mothers with hypertensive pregnancy disorders from this population are 18 
reassuring, because differences between the groups were similar for blood pressure measured 19 
before and after pregnancy.20 In that study, post-pregnancy cardiovascular risk factors could 20 
largely be attributed to pre-pregnancy risk factors, and not to a direct effect of the 21 
hypertensive pregnancy. Although our sibling comparison represents a unique design in 22 
adjusting for unmeasured (unknown) confounding factors shared by siblings, it does not 23 
exclude the possibility for confounding by un-shared factors or by misclassification of the 24 
exposure.21 Women with hypertensive pregnancy disorders may have higher blood pressure 25 
 12 
also in their normotensive pregnancies, compared with normotensive pregnancies of other 1 
women. The true difference in in utero exposure to hypertension may therefore be less in the 2 
sibling comparison.  3 
 Several studies suggest that offspring born after hypertensive disorders in pregnancy 4 
may have increased blood pressure in childhood compared to other children, but few studies 5 
have followed children into adulthood. Nonetheless, the results of others suggest that children 6 
and adolescents born after a preeclampsia pregnancy have higher blood pressure, BMI, waist 7 
circumference and serum cholesterol compared to offspring of normotensive pregnancies. A 8 
large Finnish study suggested that offspring born after preeclampsia may be at higher risk of 9 
stroke later in life, but found no association with coronary heart disease.10-12, 22-26 In a 10 
systematic review, including more than 45 000 participants, Davis et al12 reported positive 11 
associations of preeclampsia with offspring blood pressure (systolic and diastolic) and BMI 12 
that were similar to ours. It has also been suggested that the higher childhood blood pressure 13 
associated with maternal hypertension in pregnancy may persist into adulthood.27 Hence, 14 
Davis et al11 followed offspring of hypertensive pregnancy disorders into young adulthood, 15 
and found that they were 2.5 times more likely to have global lifetime risk factor levels 16 
(QRISK, a prediction algorithm for cardiovascular disease) above the 75th percentile. Few 17 
studies have examined offspring by subtype of maternal hypertensive disorder. The results of 18 
two studies suggest that maternal preeclampsia and gestational hypertension may both be 19 
associated with higher blood pressure in adolescence, but their findings suggested no 20 
association with fasting insulin, glucose, lipid levels, apolipoproteins or inflammatory 21 
markers.28, 29 22 
 An intriguing question is whether the adverse cardiovascular risk profile can be 23 
attributed to genetic or behavioral risk factors common to mothers and their offspring, or to 24 
intrauterine vascular damage or altered metabolism caused by fetal exposure to hypertension 25 
 13 
or preeclampsia.30-32 There is evidence that preeclampsia and CVD share similar risk factors33, 1 
and that cardiovascular risk factors prior to pregnancy appear to be positively associated with 2 
preeclampsia risk.34 We found that the positive associations of hypertensive pregnancy 3 
disorders with offspring blood pressure and BMI were substantially attenuated after 4 
accounting for maternal blood pressure and BMI. Furthermore, we found no differences 5 
between siblings born to the same mother where one was born after a hypertensive pregnancy, 6 
and the other(s) after a normotensive pregnancy.  7 
If cardiovascular factors could be attributed to maternal characteristics, our 8 
interpretation would be in favor of genetic effects or shared lifestyle, and conversely, if the 9 
effects could be attributed to characteristics of the pregnancy (hypertensive or not), we would 10 
lean to an interpretation where the pregnancy itself could be important for the cardiovascular 11 
risk profile later in life. In this study, we found that the differences in cardiovascular risk 12 
factors were strongly attenuated after adjustment for maternal factors, suggesting that shared 13 
genes or lifestyle may largely explain the differences. Nonetheless, the adjustment did not 14 
completely rule out the possibility that the hypertensive pregnancy in itself may cause a 15 
lasting effect on the offspring, as a slightly higher blood pressure was observed in the 16 
offspring of hypertensive pregnancies also after adjustment. However, the influence from 17 
maternal blood pressure may not be fully captured by our adjustment, because of possible 18 
measurement error due to variation in blood pressure over time. Also, by comparing siblings 19 
who were either born after a hypertensive or a normotensive pregnancy, we found that their 20 
risk factor profile did not differ, and that finding supports a hereditary or shared lifestyle 21 
interpretation of the main findings.  22 
Thus, it seems plausible that transfer of cardiovascular risk factors from mother to 23 
child may be an important explanation for our findings, and also for the higher risk of 24 
preeclampsia that has been observed in female offspring whose mothers had preeclampsia. 30, 25 
 14 
35, 36,37 However, it has also been suggested that excess cardiovascular risk in the offspring 1 
could be a long-term consequence of fetal exposure to preeclampsia.30, 31 In support of that 2 
possibility, another study using information from differentially exposed siblings, found a 3 
marked vascular dysfunction (higher pulmonary artery pressure and smaller flow-mediated 4 
dilatation) in offspring of pregnancies with late-onset preeclampsia, but normal vascular 5 
function in their siblings born after a normotensive pregnancy.38 In this study, the birth weight 6 
in offspring born after preeclampsia was 400 g lower than the controls, suggesting exposure 7 
to a more severe placental disease. Moreover, these differences in vascular function were not 8 
accompanied by differences in blood pressure and BMI, and it is unclear how these measures 9 
of vascular function correspond to the conventional cardiovascular risk factors that we 10 
examined. 11 
Many researchers claim that preterm and term preeclampsia are distinctly different 12 
diseases,39 and that different underlying mechanisms suggest that implications for later 13 
cardiovascular risk are likely to differ. Thus, the pathway to increased cardiovascular risk for 14 
mothers with a history of mild (term) preeclampsia may differ from that of mothers with a 15 
history of severe (preterm) preeclampsia.40 However, it is not known if similar patterns may 16 
be replicated in the offspring.41 42 Unfortunately, low statistical power in our study precludes 17 
any definite answer to these questions. Another interesting aspect of preterm preeclampsia is 18 
the time-related improvement in prognosis for children born after these pregnancies. The 19 
increasingly better survival of these children may also have implications for their future 20 
cardiovascular health.  21 
 22 
Perspectives 23 
Our findings confirm that offspring of mothers with hypertensive disorders in pregnancy have 24 
a cardiovascular risk profile in young adulthood that indicates increased risk of CVD later in 25 
 15 
life. This association was substantially, but not fully, attenuated after accounting for maternal 1 
cardiovascular risk factors. Cardiovascular risk factor levels were similar for siblings who 2 
were either exposed or unexposed to hypertension in utero. Although a long-term effect of the 3 
hypertensive pregnancy cannot be ruled out, most of the added risk in the offspring may be 4 
attributed to a shared environment or to shared genetic factors with the mother. If that 5 
interpretation is correct, all children of a mother who has experienced one or more 6 
hypertensive pregnancies may be at increased lifetime risk of cardiovascular disease.  7 
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Novelty and significance: 1 
What is new: 2 
 Cardiovascular risk factors in adults born by a mother with hypertension in pregnancy 3 
may be attributed to a shared environment or to shared genetic factors with the mother 4 
 5 
What is relevant: 6 
 All children of a mother who has experienced one or more hypertensive pregnancies 7 
may be at increased lifetime risk of cardiovascular disease 8 
 9 
Summary: 10 
Offspring born after maternal hypertension in pregnancy have a more adverse cardiovascular 11 
risk profile in young adulthood than offspring of normotensive pregnancies. Their siblings, 12 
born after a normotensive pregnancy, have a similar risk profile, suggesting that shared 13 
genetics/lifestyle may account for the added risk.  14 
 20 
Table 1. Maternal and offspring characteristics according to hypertension status of the 1 
mother’s pregnancy, given as mean (SD) unless otherwise noted.   2 
  3 
Hypertension status 
 
N (participants) 
N (observations) 
No HT*  
 
15 072 
18 732 
Any HT  
 
706 
864 
Gestational HT  
 
336 
411 
Term PE† 
 
343 
422 
Preterm PE  
 
27 
31 
      
Maternal characteristics      
    Age at delivery, years 
 
25.7 (5.4) 26.7 (6.0) 27.5 (6.3) 26.0 (5.7) 25.4 (5.2) 
    Parity at delivery, % 
          0 
          1 
          ≥2 
 
    Body mass index, kg/m2 ‡ 
 
    Weight, kgc 
 
    Current daily smokers, %c 
  
    Education, %c 
        ≤9 years 
        10-12 years 
        >12 years 
          
 
 
37.4 
33.1 
29.6 
 
24.1 (3.9) 
 
65.7 (11.2) 
 
39.3 
 
 
51.4 
36.2 
12.3 
 
49.6 
24.4 
26.1 
 
26.6 (5.2) 
 
72.9 (15.0) 
 
22.7 
 
 
50.3 
36.9 
12.9 
 
40.8 
26.8 
32.4 
 
26.9 (5.2) 
 
73.9 (14.7) 
 
23.6 
 
 
54.0 
35.4 
10.5 
 
57.1 
22.4 
20.4 
 
26.4 (5.2) 
 
72.3 (15.4) 
 
22.9 
 
 
47.5 
37.3 
15.1 
 
63.0 
18.5 
18.5 
 
25.4 (4.9) 
 
68.3 (13.5) 
 
9.1 
 
 
36.4 
50.0 
13.6 
Offspring characteristics      
    Male attendants, % 
    Female attendants, % 
 
    Gestational age, % 
        <34 weeks 
         34-36 weeks 
         ≥37 weeks 
44.3 
55.7 
 
 
0.9 
3.0 
96.1 
43.3 
56.7 
 
 
1.2 
4.0 
94.8 
41.7 
58.3 
 
 
0.3 
2.1 
97.5 
45.2 
54.8 
 
 
0.0 
0.0 
100.0 
40.7 
59.3 
 
 
25.9 
74.1 
0.0 
 
    Infant birth length, cm 
 
 
 
50.8 (2.2) 
 
50.6 (2.8) 
 
51.1 (2.3) 
 
50.4 (2.6) 
 
44.9 (3.8) 
    Birth weight, grams  
 
3535 (529) 3432 (669) 3573 (558) 3399 (651) 2094 (629) 
    Head circumference at                
birth, cm  
35.2 (1.5) 35.1 (1.8) 35.2 (1.6) 35.2 (1.6) 31.3 (3.4) 
    Age at follow-up, years 28.9 (6.2) 
 
28.4 (6.1) 28.0 (5.8) 28.8(6.3) 29.1 (6.8)  
    Current daily smokers , %c 21.7 20.9 21.1 20.8 20.0  
  
 
 
 
 
 
 
 
 
 
 
 
*HT= hypertension 4 
†PE = preeclampsia 5 
‡As recorded in the Nord-Trøndelag Health (HUNT) Study. Maternal characteristics were collected from the earliest HUNT 6 
examination in which the mother participated 7 
 8 
  9 
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Table 2. Cardiovascular risk factors in adult offspring by exposure to any maternal 1 
hypertensive disorder, gestational hypertension or preeclampsia, shown as mean differences 2 
(95% CI*) compared to offspring born after normotensive pregnancy (adjusted for age, sex, 3 
maternal parity and HUNT survey). N=15 778 participants with 19 596 observations†. 4 
  5 
 Mean value (95% 
CI†) 
Mean differences (95% CI) from the No HT‡ group 
Hypertension 
status in utero 
 
N (participants) 
N (observations) 
No HT 
 
 
15 072 
18 732 
Any HT  
 
 
706 
864 
Gestational HT  
 
 
336 
411 
Term PE§ 
 
 
343 
422 
Pre-term PE  
 
 
27 
31 
      
Systolic blood 
pressure, mmHg 
 
123.0 
(122.8, 123.2) 
2.7 
(1.8, 3.5) 
3.3 
(1.9, 4.6) 
2.3 
(1.1, 3.5) 
-0.6 
(-4.3, 3.1) 
Diastolic blood 
pressure, mmHg 
 
69.3 
(69.1, 69.4) 
1.5 
(0.9, 2.1) 
2.1 
(1.2, 3.0) 
1.0 
(0.1, 1.9) 
0.0 
(-2.1, 2.2) 
Body mass index, 
kg/m2 
 
 
25.63 
(25.56, 25.70) 
0.66 
(0.31, 1.01) 
0.48 
(0.00, 0.97) 
0.93 
(0.41, 1.44) 
-0.78 
(-2.05, 0.49) 
Waist 
circumference, cm 
 
 
85.81 
(85.63, 85.99) 
 
1.49 
(0.65, 2.33) 
 
1.25 
(0.10, 2.41) 
 
1.86 
(0.63, 3.09) 
-0.50 
(-4.74, 3.75) 
Waist-hip ratio 
 
 
0.840 
(0.839, 0.841) 
0.003 
(-0.002, 0.008) 
0.000 
(-0.006, 0.006) 
0.006 
(-0.001, 0.013) 
0.007 
(-0.018, 0.031) 
HDL cholesterol||, 
mmol/L 
1.33 
(1.32, 1.33) 
-0.02 
(-0.04, 0.01) 
-0.02 
(-0.05, 0.01) 
-0.01 
(-0.05, 0.02) 
-0.02 
(-0.16, 0.12) 
Non-HDL 
cholesterol, 
mmol/L 
3.56 
(3.54, 3.57) 
0.09 
(0.01, 0.16) 
0.03 
(-0.07, 0.13) 
0.14 
(0.03, 0.25) 
0.14 
(-0.17, 0.44) 
 
Triglycerides, 
mmol/L 
 
1.21 
(1.20, 1.22) 
 
 
0.05 
(0.00, 0.11) 
 
-0.03 
(-0.09, 0.05) 
 
0.13 
(0.06, 0.21) 
 
0.17 
(-0.06, 0.43) 
 
C-reactive protein, 
mg/L 
 
1.10 
(1.06, 1.14) 
 
0.05 
(-0.06, 0.18) 
 
 
0.08 
(-0.09, 0.28) 
 
0.01 
(-0.14, 0.18) 
 
0.38 
(-0.18, 1.28) 
*CI = confidence interval 6 
†Number of observations for the different variables: Systolic and diastolic blood pressure n=19 480, Body mass index n=19 526, 7 
Waist circumference n=19 234, Waist-hip ratio n=19 232, HDL and non-HDL cholesterol n=19 159, Triglycerides n=19 361, C-8 
reactive protein n=12 229. 9 
‡HT= hypertension 10 
§PE = preeclampsia 11 
||HDL = high density lipoprotein   12 
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Table 3. Cardiovascular risk factors in adult offspring by exposure to any maternal 1 
hypertensive disorder, gestational hypertension or preeclampsia, shown as mean differences 2 
(95 % CI*) compared to offspring born after a normotensive pregnancy. The analysis includes 3 
13 127 participants (with 16 584 observations) with available data on maternal cardiovascular 4 
risk factors in the HUNT Study.   5 
  6 
  Model 1† 
(CI) 
Model 2‡ 
(CI) 
Model 3§ 
(CI) 
Model 4|| 
(CI) 
       
Systolic blood 
pressure, 
mmHg 
 
 2.6 (1.6, 3.5) 
 
2.7 (1.7, 3.6) 
 
2.2 (1.2, 3.1) 
 
1.0 (0.1,2.0) 
  
Diastolic blood 
pressure, 
mmHg 
 
 1.5 (0.7, 2.2) 
 
1.5 (0.8, 2.2) 
 
1.3 (0.6, 2.0) 
 
0.5 (-0.2, 1.2) 
 
Body mass 
index, kg/m2 
 
 0.56 (0.18, 0.93) 
 
 
0.70 (0.33, 1.08) 
 
0.06 (-0.31, 0.43) 
 
0.11 (-0.26, 0.48) 
 
Waist 
circumference, 
cm 
 
 1.24 (0.35, 2.14) 
 
 
1.57 (0.67, 2.47) 
 
0.13 (-0.75, 1.02) 
 
0.13 (-0.76, 1.02) 
 
Waist-hip ratio 
 
 
 0.002 (-0.003, 0.007) 
 
0.004 (-0.001, 0.009) 
 
-0.001 (-0.006, 0.004) 
 
-0.002 (-0.006, 0.003) 
 
HDL 
cholesterol¶, 
mmol/L 
 -0.02 (-0.04, 0.01) 
 
-0.02 (-0.05, 0.01) 
 
-0.01 (-0.04, 0.02) 
 
-0.01 (-0.04, 0.02) 
 
 
Non-HDL 
cholesterol, 
mmol/L 
 
 
 
0.08 (0.00, 0.16) 
 
 
0.11 (0.03, 0.19) 
 
 
0.06 (-0.02, 0.14) 
 
 
0.05 (-0.03, 0.13) 
 
 
Triglycerides, 
mmol/L 
 
 
 
0.05 (0.00, 0.11) 
 
 
 
0.06 (0.01, 0.12) 
 
 
0.04 (-0.01, 0.10) 
 
 
 
0.03 (-0.03, 0.08) 
 
 
C-reactive 
protein, mg/L 
 
 
 
0.08 (-0.05, 0.22) 
 
 
0.10 (-0.03, 0.25) 
 
 
0.03 (-0.10, 0.16) 
 
 
0.03 (-0.10, 0.17) 
 
* CI = confidence interval 7 
† Model 1: adjusted for age, sex, maternal parity and HUNT survey 8 
‡ Model 2: adjusted for age, sex, maternal parity, HUNT survey, maternal smoking and maternal education  9 
§ Model 3: adjusted for age, sex, maternal parity, HUNT survey, maternal smoking, maternal education and maternal BMI 10 
|| Model 4: adjusted for age, sex, maternal parity, HUNT survey, maternal smoking, maternal education, maternal BMI, maternal 11 
systolic blood pressure and maternal diastolic blood pressure 12 
¶HDL = high density lipoprotein  13 
  14 
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Table 4. Characteristics of the 472 offspring included in the sibling analysis, by hypertension 1 
status of the mother’s pregnancy, given as mean (SD) unless otherwise noted.  2 
 3 
Hypertension status 
 
No 
hypertension 
(n = 254) 
Any 
hypertension  
(n = 218) 
   
Male attendants, % 
Female attendants, % 
49.6 
50.4 
42.2 
57.8 
 
Maternal age at delivery, 
years 
 
25.1 (4.7) 25.9 (5.3) 
Maternal parity at 
delivery, % 
        0 
        1 
        ≥2 
 
      
 
25.6 
48.0 
26.4 
 
 
45.9 
24.8 
29.4    
Gestational age, % 
        <34 weeks 
         34-36 weeks 
         ≥37 weeks 
 
1.3 
1.7 
97.1 
 
1.4 
1.9 
96.7 
 
Infant birth length, cm 
 
 
51.1 (2.1) 
 
50.8 (2.4) 
Birth weight, grams  
 
3605 (544) 3498 (651) 
Head circumference at          
birth, cm  
35.2 (1.3) 35.4 (1.7) 
Age at follow-up, years 29.1 (6.2) 
 
29.8 (6.0) 
Current daily smokers at 
follow-up , % 
 
19.4 19.9 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
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Table 5. Sibling analysis: Mean differences in cardiovascular risk factors in adult offspring 1 
exposed to maternal hypertensive disorder compared to their unexposed siblings, adjusted for 2 
age, sex, maternal parity and HUNT survey. The analysis includes 210 sibling groups where 3 
at least one sibling was born after hypertensive pregnancy and at least one sibling was born 4 
after normotensive pregnancy (total n = 472). 5 
 6 
Risk factors N (observations) Mean differences (95% CI*) between siblings exposed to 
maternal hypertensive disorder of pregnancy and their 
siblings born after normotensive pregnancy 
   
Systolic blood pressure, mmHg 
 
470 -0.7 (-3.0, 1.5) 
Diastolic blood pressure, mmHg 
 
470 -0.8 (-2.6, 0.9) 
Body mass index, kg/m2 
 
470 0.01 (-0.74, 0.75) 
Waist circumference, cm 
 
463 -0.09 (-2.09, 1.91) 
Waist-hip ratio 
 
463 -0.001 (-0.013, 0.010) 
HDL cholesterol†, mmol/L 
 
459 -0.02 (-0.07, 0.04) 
Non-HDL cholesterol, mmol/L 459 0.11 (-0.07, 0.29) 
 
Triglycerides, mmol/L 
 
461 
 
-0.01 (-0.13, 0.13) 
 
C-reactive protein, mg/L 
 
267 
 
-0.10 (-0.41, 0.34) 
*CI = confidence interval 7 
†HDL = high density lipoprotein 8 
 9 
 10 
 11 
  12 
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Table 6. Mean differences (95% CI*) in cardiovascular risk factors among offspring born 1 
after hypertensive pregnancy (n=706), and offspring born after normotensive pregnancy but 2 
whose mother had at least one hypertensive pregnancy (n=653), compared to offspring of 3 
women with no record of hypertensive pregnancy (n=14 419) (adjusted for age, sex, maternal 4 
parity and HUNT survey). 5 
 6 
Risk factors Born after hypertensive 
pregnancy 
Born after normotensive pregnancy, but with a  
mother who had at least one hypertensive 
pregnancy 
   
Systolic blood pressure, mmHg 
 
2.6 (1.7, 3.5) 2.8 (1.9, 3.8) 
Diastolic blood pressure, mmHg 
 
1.5 (0.9, 2.2) 1.8 (1.0, 2.5) 
Body mass index, kg/m2 
 
0.52 (0.18, 0.86) 0.49 (0.13, 0.85) 
Waist circumference, cm 
 
1.15 (0.26, 2.04) 1.44 (0.50, 2.38) 
Waist-hip ratio 
 
0.002 (-0.003, 0.007) 0.006 (0.001, 0.011) 
HDL cholesterol† mmol/L 
 
-0.01 (-0.04, 0.01) -0.01 (-0.02, 0.03) 
Non-HDL cholesterol, mmol/L 0.07 (0.00, 0.14) -0.01 (-0.08, 0.07) 
 
Triglycerides, mmol/L 
 
0.03 (-0.02, 0.08) 
 
0.01 (-0.04, 0.07) 
 
C-reactive protein, mg/L 
 
0.05 (-0.06, 0.18) 
 
0.11 (-0.02, 0.26) 
*CI = confidence interval 7 
†HDL = high density lipoprotein 8 
 9 
